文献速递乳腺癌

荷兰人群研究:乳腺导管原位癌分级与乳腺癌特异性死亡的关系

Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012.
PubMed 文献 · Eur J Cancer · 2018-07-28

该研究基于荷兰癌症登记库1999–2012年确诊的12256例导管原位癌(DCIS)患者,分析术后不同分级与乳腺癌特异性生存(BCSS)和总生存(OS)的关系。中位随访7.8年,仅1.5%死亡与乳腺癌相关;校正混杂后,II级和III级较I级BCSS更差(HR分别为1.92和2.14),分级与OS无关。作者认为低级别DCIS预后优越,值得探索主动监测替代常规手术。

要点

  • DCIS术后BCSS和OS均极佳,乳腺癌相关死亡仅占1.5%。
  • 校正混杂后,II级和III级DCIS的BCSS较I级更差。
  • 分级与总生存无关,低级别DCIS或可考虑主动监测。

核心结论

  • DCIS患者术后BCSS和OS均极佳,乳腺癌相关死亡罕见。
  • 校正混杂后,II级和III级DCIS的BCSS较I级更差,但分级与OS无关。
  • 低级别DCIS预后优越,值得研究主动监测作为常规手术替代方案的可行性。

研究设计与样本

  • 基于荷兰癌症登记库的人群回顾性队列研究,纳入1999–2012年确诊的DCIS患者。
  • 共纳入12256例患者,其中I级1509例(12.3%)、II级3675例(30.0%)、III级6064例(49.5%)、分级未知1008例(8.2%)。
  • 死因信息来自荷兰统计局,采用多变量Cox回归估计BCSS和OS,并在全队列及按分级分层分析。
  • 中位随访7.8年。

主要发现

  • 随访期间共观察到1138例(9.3%)死亡,其中179例(1.5%)为乳腺癌相关死亡。
  • 乳腺癌相关死亡中,I级10例、II级46例、III级95例、分级未知28例。
  • 校正混杂后,II级和III级DCIS的BCSS较I级更差,风险比分别为1.92(95%CI 0.97–3.81)和2.14(95%CI 1.11–4.12)。
  • 未观察到分级与OS之间存在关联。

临床怎么用

  • DCIS术后预后总体良好,应向患者传递BCSS和OS极佳的信息。
  • 对于低级别DCIS,可考虑与患者讨论主动监测作为常规手术的潜在替代方案,但需进一步研究验证。
  • 分级可作为DCIS预后分层参考,II级和III级患者BCSS相对较差,应加强随访管理。

局限性

  • 本研究为回顾性队列研究,可能存在选择偏倚和残余混杂。
  • 分级未知患者占8.2%,可能影响分级相关结果的准确性。
  • 主动监测的可行性仅为基于低级别DCIS预后优越的推论,尚未经干预性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The incidence of ductal carcinoma in situ (DCIS) has drastically increased over the past decades. Because DCIS is resected after diagnosis similar to invasive breast cancer, the natural cause and behaviour of DCIS is not well known. We aimed to determine breast cancer-specific survival (BCSS) and overall survival (OS) according to grade in DCIS patients after surgical treatment in the Netherlands. PATIENTS AND METHODS: All DCIS patients diagnosed between 1999 and 2012 were selected from the Netherlands Cancer Registry. The cause of death was obtained from 'Statistics Netherlands'. BCSS and OS were estimated using multivariable Cox regression in the entire cohort and stratified for grades. RESULTS: In total, 12,256 patients were included, of whom 1509 (12.3%) presented with grade I, 3675 (30.0%) with grade II, 6064 (49.5%) with grade III and 1008 (8.2%) with an unknown grade. During a median follow-up of 7.8 years, 1138 (9.3%) deaths were observed, and 179 (1.5%) were breast cancer-related. Of these, 10 patients had grade I; 46 grade II; 95 grade III and 28 an unknown grade. After adjustment for confounding, grade II and III were related to worse BCSS than grade I with hazard ratios of 1.92 (95% confidence interval [CI]: 0.97-3.81) and 2.14 (95% CI: 1.11-4.12), respectively. No association between grades and OS was observed. CONCLUSION: BCSS and OS in DCIS patients were excellent. Because superior rates were observed for low-grade DCIS, it seems justified to investigate whether active surveillance may be a balanced alternative for conventional surgical treatment.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. van Maaren MC, Lagendijk M, Tilanus-Linthorst MMA, et al. Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012. Eur J Cancer. 2018. PMID: 30059817. doi:10.1016/j.ejca.2018.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。